BioCentury
ARTICLE | Financial News

Capnia financial update

February 3, 2017 5:34 PM UTC

On Jan. 27, inflammation, neurology and diagnostic company Capnia Inc. (NASDAQ:CAPN) entered into a 30-month stock purchase agreement with Aspire Capital Fund for up to $17 million....

BCIQ Company Profiles

Soleno Therapeutics Inc.